Satralizumab

About Chugai Pharmaceutical

Chugai Pharmaceutical Co., Ltd. is Japan's premier biotechnology company and a subsidiary of Roche, focusing on precision medicine and innovative drug development. Founded in 1925, the company has built a strong portfolio in oncology, autoimmune diseases, and rare conditions through both in-house R&D and strategic partnerships with Roche. Chugai operates as Roche's key development and commercialization hub in Japan while maintaining its independent research capabilities and Tokyo Stock Exchange listing.

Therapeutic Areas